Fundraising FoxLiposeuticals
1 known investors
Find your way into Liposeuticals
Sign up to see every warm intro you have to Liposeuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Liposeuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Liposeuticals develops proprietary formulations of sterile injectable drugs for hospital use, focusing on anesthesiology, oncology, and infectious disease treatments. The company's sugar-lipid polymer technology platform reformulates water-insoluble compounds to improve stability, shelf life, manufacturability, and patient safety compared to existing emulsion-based approaches.
Investors · 1
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of DefenseDefense Health Program | Phase ISTTR | 2017 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Liposeuticals do?
- Liposeuticals develops proprietary formulations of sterile injectable drugs for hospital use, focusing on anesthesiology, oncology, and infectious disease treatments. The company's sugar-lipid polymer technology platform reformulates water-insoluble compounds to improve stability, shelf life, manufacturability, and patient safety compared to existing emulsion-based approaches.
- Who are Liposeuticals's investors?
- Liposeuticals's investors include Delos Capital.